{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:37:13Z","timestamp":1774895833864,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jval.2015.08.003","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T12:35:21Z","timestamp":1442406921000},"page":"1088-1097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Using Decision-Analytic Modeling to Isolate Interventions That Are Feasible, Efficient and Optimal: An Application from the Norwegian Cervical Cancer Screening Program"],"prefix":"10.1016","volume":"18","author":[{"given":"Kine","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sveinung Wergeland","family":"S\u00f8rbye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily Annika","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"L\u00f6nnberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivar S\u00f8nb\u00f8","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.jval.2015.08.003_bib1","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/cncr.11680","article-title":"Decision science and cervical cancer","volume":"98","author":"Cantor","year":"2003","journal-title":"Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.jval.2015.08.003_bib2","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.vaccine.2006.05.112","article-title":"Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling","volume":"24","author":"Goldie","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jval.2015.08.003_bib3","series-title":"Cancer in Norway 2011\u2014Cancer Incidence, Mortality, Survival and Prevalence in Norway","year":"2013"},{"key":"10.1016\/j.jval.2015.08.003_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1055-9965.EPI-04-0569","article-title":"Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening","volume":"14","author":"Bray","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jval.2015.08.003_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2046-4053-2-35","article-title":"Screening for cervical cancer: a systematic review and meta-analysis","volume":"2","author":"Peirson","year":"2013","journal-title":"Syst Rev"},{"key":"10.1016\/j.jval.2015.08.003_bib6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/bjc.2014.362","article-title":"50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence","volume":"111","author":"Vaccarella","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jval.2015.08.003_bib7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1471-0528.2002.99023.x","article-title":"The psychological impact of abnormal cytology and colposcopy","volume":"109","author":"Rogstad","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.jval.2015.08.003_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/LGT.0b013e31829c97d8","article-title":"TOMBOLA Group. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance","volume":"18","author":"Sharp","year":"2014","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jval.2015.08.003_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2013.11.001","article-title":"How distressing is referral to colposcopy in cervical cancer screening? A prospective quality of life study","volume":"132","author":"Korfage","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jval.2015.08.003_bib10","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1471-0528.2009.02263.x","article-title":"After-effects reported by women following colposcopy, cervical biopsies and LLETZ: results from the TOMBOLA trial","volume":"116","author":"Sharp","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.jval.2015.08.003_bib11","doi-asserted-by":"crossref","first-page":"a1343","DOI":"10.1136\/bmj.a1343","article-title":"Pregnancy outcome in women before and after cervical conisation: population based cohort study","volume":"337","author":"Albrechtsen","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2015.08.003_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2015.08.003_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jval.2015.08.003_bib14","unstructured":"Official Norwegian Guidelines in Gynecological Oncology. Norwegian Society for Gynecology Obstetrics, Troms\u00f8, Bergen, and L\u00f8renskog, Norway, 2009."},{"key":"10.1016\/j.jval.2015.08.003_bib15","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/bjc.2012.94","article-title":"Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway","volume":"106","author":"Burger","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jval.2015.08.003_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1478-7954-5-11","article-title":"Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination","volume":"5","author":"Goldhaber-Fiebert","year":"2007","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.jval.2015.08.003_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/eurpub\/cki163","article-title":"The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany","volume":"16","author":"Siebert","year":"2006","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.jval.2015.08.003_bib18","unstructured":"Norwegian Directorate of Health. Economic evaluation of health interventions\u2014a guide. Available from: http:\/\/helsedirektoratet.no\/publikasjoner\/okonomisk-evaluering-av-helsetiltak--en-veileder\/Publikasjoner\/IS-1985.pdf. [Accessed September 15, 2014]."},{"key":"10.1016\/j.jval.2015.08.003_bib19","unstructured":"Norwegian Official Report on Economic Evaluations. NOU 2012:16. Available from: https:\/\/www.regjeringen.no\/contentassets\/5fce956d51364811b8547eebdbcde52c\/no\/pdfs\/nou201220120016000dddpdfs.pdf [Accessed September 8, 2015]."},{"key":"10.1016\/j.jval.2015.08.003_bib20","series-title":"Handbooks in Health Economic Evaluation Series","article-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.jval.2015.08.003_bib21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jval.2012.04.012","article-title":"Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7","volume":"15","author":"Eddy","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2015.08.003_bib22","unstructured":"TreeAge Pro 2014 User\u2019s Manual. 2014. Available from: http:\/\/installers.treeagesoftware.com\/treeagepro\/14.1.0\/PDF\/TP-Manual-2014R1.pdf. [Accessed September 15, 2014]."},{"key":"10.1016\/j.jval.2015.08.003_bib23","unstructured":"Norwegian Medical Association. Normal Tariff for Private General Practice 2012\u20132013. Oslo, Norway, 2012."},{"key":"10.1016\/j.jval.2015.08.003_bib24","unstructured":"Cancer Registry of Norway. The Norwegian Cervical Cancer Screening Program. The Cancer Registry of Norway, Oslo, Norway, 2011."},{"key":"10.1016\/j.jval.2015.08.003_bib25","doi-asserted-by":"crossref","first-page":"e24083","DOI":"10.1371\/journal.pone.0024083","article-title":"Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology","volume":"6","author":"Sorbye","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2015.08.003_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/AOG.0b013e3181e3e719","article-title":"The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer","volume":"116","author":"Castle","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jval.2015.08.003_bib27","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1055-9965.EPI-11-0206","article-title":"A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study","volume":"20","author":"Schiffman","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jval.2015.08.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13510","article-title":"ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening","volume":"13","author":"Kitchener","year":"2009","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jval.2015.08.003_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jval.2015.08.003_bib30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial","volume":"98","author":"Ronco","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jval.2015.08.003_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","article-title":"Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial","volume":"7","author":"Ronco","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jval.2015.08.003_bib32","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/ijc.27723","article-title":"Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions","volume":"132","author":"Cuzick","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jval.2015.08.003_bib33","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/bjc.2011.581","article-title":"HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications","volume":"106","author":"Rijkaart","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jval.2015.08.003_bib34","first-page":"Cd008054","article-title":"Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions","volume":"3","author":"Arbyn","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl. 5","key":"10.1016\/j.jval.2015.08.003_bib35","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jval.2015.08.003_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jval.2015.08.003_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1309\/EWYGWFRRM8798U5P","article-title":"The risk of false-positive histology according to the reason for colposcopy referral in cervical cancer screening: a blind revision of all histologic lesions found in the NTCC trial","volume":"129","author":"Dalla Palma","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jval.2015.08.003_bib38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejogrb.2010.12.002","article-title":"Outcome of expectant management of cervical intraepithelial neoplasia grade 2 in women followed for 12 months","volume":"155","author":"Discacciati","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jval.2015.08.003_bib39","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1158\/1055-9965.EPI-10-1187","article-title":"Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women","volume":"20","author":"Gheit","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jval.2015.08.003_bib40","doi-asserted-by":"crossref","first-page":"8813","DOI":"10.1158\/0008-5472.CAN-08-1380","article-title":"Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study","volume":"68","author":"Goodman","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jval.2015.08.003_bib41","first-page":"2319","article-title":"Short-term outcome of cervical intraepithelial neoplasia grade 2: considerations for management strategies and reproducibility of diagnosis","volume":"30","author":"Guedes","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jval.2015.08.003_bib42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/147323001204000210","article-title":"Factors affecting the clearance of high-risk human papillomavirus infection and the progression of cervical intraepithelial neoplasia","volume":"40","author":"Kim","year":"2012","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jval.2015.08.003_bib43","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jmv.21750","article-title":"Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women","volume":"82","author":"Nielsen","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.jval.2015.08.003_bib44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ajog.2008.06.033","article-title":"Persistence and clearance of human papillomavirus infection: a prospective cohort study","volume":"199","author":"Rosa","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jval.2015.08.003_bib45","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/ijc.25470","article-title":"The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials","volume":"128","author":"Stoler","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jval.2015.08.003_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ajog.2010.05.033","article-title":"Diagnostic accuracy of guided cervical biopsies: a prospective multicenter study comparing the histopathology of simultaneous biopsy and cone specimen","volume":"203","author":"Zuchna","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jval.2015.08.003_bib47","unstructured":"Pedersen K, Burger E, L\u00f6nnberg S, et al. Vedlegg 2: Kostnader og kostnadseffektivitet ved innf\u00f8ring av HPV-test i prim\u00e6rscreening for livmorhalskreft. 2013. Available from: http:\/\/www.helsedirektoratet.no\/helse-og-omsorgstjenester\/kreft\/screening\/hpv-screening\/styringsgruppe\/Documents\/Kostnader%20og%20kostnadseffektivitet%20ved%20innf%C3%B8ring%20av%20HPV-test%20i%20prim%C3%A6rscreening%20for%20livmorhalskreft.pdf. [Accessed July 1, 2014]."},{"key":"10.1016\/j.jval.2015.08.003_bib48","unstructured":"Norwegian Medical Association. Normal Tariff for Private General Practice 2012\u20132013. Norwegian Medical Association, Oslo, Norway, 2012."},{"key":"10.1016\/j.jval.2015.08.003_bib49","unstructured":"Norwegian Medical Association. Normal Tariff for Private Specialist Practice 2011-2012. Norwegian Medical Association, Oslo, Norway, 2012."},{"key":"10.1016\/j.jval.2015.08.003_bib50","unstructured":"Norwegian Directorate of Health. Activity-based funding 2013. 2013. Available from: http:\/\/www.helsedirektoratet.no\/finansiering\/isf\/regelverket-for-isf\/tidligere-regelverk\/Documents\/ISF_2013.pdf. [Accessed April 14, 2014]."},{"key":"10.1016\/j.jval.2015.08.003_bib51","unstructured":"Statistics Norway. 2012. Available from: http:\/\/www.ssb.no\/english. [Accessed September 1, 2013]."},{"key":"10.1016\/j.jval.2015.08.003_bib52","unstructured":"Moger TA, Kristiansen IS. Direct and indirect costs of the Norwegian Breast Cancer Screening Program. HERO Working Paper 2012:3. Available from: http:\/\/www.med.uio.no\/helsam\/forskning\/nettverk\/hero\/publikasjoner\/skriftserie\/2012\/hero2012-3.pdf. [Accessed August 6, 2015]."},{"key":"10.1016\/j.jval.2015.08.003_bib53","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/ijc.28838","article-title":"The value of improving failures within a cervical cancer screening program: an example from Norway","volume":"135","author":"Burger","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jval.2015.08.003_bib54","series-title":"Annual Report 2012","article-title":"Masseunders\u00f8kelsen mot livmorhalskreft","author":"Skare","year":"2014"},{"key":"10.1016\/j.jval.2015.08.003_bib55","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study","volume":"50","author":"Szarewski","year":"2012","journal-title":"J Clin Microbiol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301515020318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301515020318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T06:00:09Z","timestamp":1537336809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301515020318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1098301515020318"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2015.08.003","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using Decision-Analytic Modeling to Isolate Interventions That Are Feasible, Efficient and Optimal: An Application from the Norwegian Cervical Cancer Screening Program","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2015.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}